Park HL - Search Results

1

Differential recognition of response elements determines target gene specificity for p53 and p63.

Osada M, Park HL, Nagakawa Y, Yamashita K, Fomenkov A, Kim MS, Wu G, Nomoto S, Trink B, Sidransky D. Osada M, et al. Among authors: park hl. Mol Cell Biol. 2005 Jul;25(14):6077-89. doi: 10.1128/MCB.25.14.6077-6089.2005. Mol Cell Biol. 2005. PMID: 15988020 Free PMC article.

2

p63-specific activation of the BPAG-1e promoter.

Osada M, Nagakawa Y, Park HL, Yamashita K, Wu G, Kim MS, Fomenkov A, Trink B, Sidransky D. Osada M, et al. Among authors: park hl. J Invest Dermatol. 2005 Jul;125(1):52-60. doi: 10.1111/j.0022-202X.2005.23801.x. J Invest Dermatol. 2005. PMID: 15982302 Free article.

3

A novel response element confers p63- and p73-specific activation of the WNT4 promoter.

Osada M, Park HL, Nagakawa Y, Begum S, Yamashita K, Wu G, Kim MS, Trink B, Sidransky D. Osada M, et al. Among authors: park hl. Biochem Biophys Res Commun. 2006 Jan 27;339(4):1120-8. doi: 10.1016/j.bbrc.2005.11.118. Epub 2005 Dec 5. Biochem Biophys Res Commun. 2006. PMID: 16343436

4

A p53-type response element in the GDF15 promoter confers high specificity for p53 activation.

Osada M, Park HL, Park MJ, Liu JW, Wu G, Trink B, Sidransky D. Osada M, et al. Among authors: park mj, park hl. Biochem Biophys Res Commun. 2007 Mar 23;354(4):913-8. doi: 10.1016/j.bbrc.2007.01.089. Epub 2007 Jan 25. Biochem Biophys Res Commun. 2007. PMID: 17276395 Free PMC article.

5

HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma.

Yamashita K, Kim MS, Park HL, Tokumaru Y, Osada M, Inoue H, Mori M, Sidransky D. Yamashita K, et al. Among authors: park hl. Mol Cancer Res. 2008 Jan;6(1):31-41. doi: 10.1158/1541-7786.MCR-07-0213. Mol Cancer Res. 2008. PMID: 18234960 Free article.

6

The role of PGP9.5 as a tumor suppressor gene in human cancer.

Tokumaru Y, Yamashita K, Kim MS, Park HL, Osada M, Mori M, Sidransky D. Tokumaru Y, et al. Among authors: park hl. Int J Cancer. 2008 Aug 15;123(4):753-9. doi: 10.1002/ijc.23354. Int J Cancer. 2008. PMID: 18512240 Free PMC article.

7

Altered sumoylation of p63alpha contributes to the split-hand/foot malformation phenotype.

Huang YP, Wu G, Guo Z, Osada M, Fomenkov T, Park HL, Trink B, Sidransky D, Fomenkov A, Ratovitski EA. Huang YP, et al. Among authors: park hl. Cell Cycle. 2004 Dec;3(12):1587-96. doi: 10.4161/cc.3.12.1290. Epub 2004 Dec 7. Cell Cycle. 2004. PMID: 15539951

8

PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma.

Mandelker DL, Yamashita K, Tokumaru Y, Mimori K, Howard DL, Tanaka Y, Carvalho AL, Jiang WW, Park HL, Kim MS, Osada M, Mori M, Sidransky D. Mandelker DL, et al. Among authors: park hl. Cancer Res. 2005 Jun 1;65(11):4963-8. doi: 10.1158/0008-5472.CAN-04-3923. Cancer Res. 2005. PMID: 15930319

9

N-methyl-D-aspartate receptor type 2B is epigenetically inactivated and exhibits tumor-suppressive activity in human esophageal cancer.

Kim MS, Yamashita K, Baek JH, Park HL, Carvalho AL, Osada M, Hoque MO, Upadhyay S, Mori M, Moon C, Sidransky D. Kim MS, et al. Among authors: park hl. Cancer Res. 2006 Apr 1;66(7):3409-18. doi: 10.1158/0008-5472.CAN-05-1608. Cancer Res. 2006. PMID: 16585162

10

PGP9.5 methylation in diffuse-type gastric cancer.

Yamashita K, Park HL, Kim MS, Osada M, Tokumaru Y, Inoue H, Mori M, Sidransky D. Yamashita K, et al. Among authors: park hl. Cancer Res. 2006 Apr 1;66(7):3921-7. doi: 10.1158/0008-5472.CAN-05-1511. Cancer Res. 2006. PMID: 16585221

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters